HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CBUS

Cibus, Inc. (NASDAQ)

Healthcare — Biotechnology

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

None 3 analysts
$1.42
+$0.05 (+3.65%)
Target: $14.67 (932.9%)
Sign in to add CBUS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$114.98M
P/E Ratio (TTM)-
Forward P/E-2.25
EPS (TTM)$-1.77
Dividend Yield-
Profit Margin-
Revenue Growth62.60%
ROE-190.12%
Debt/Equity778.33
Recommendation None
Analyst Target$14.67
Analysts3
Indexes NASDAQ

Technical Indicators

RSI (14)68.3
Beta1.65
SMA 20-
SMA 40-
52-Week High$4.19
52-Week Low$1.09
50-Day Avg$1.39
200-Day Avg$1.79
Avg Volume394.1K
Volume121.6K

Performance Analysis

BULLISH

CBUS shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 11% of its 52-week range.
+ RSI at 68.3 shows positive momentum.
+ Strong revenue growth of 62.6% year-over-year.
~ Wall Street consensus is "none" from 3 analysts.
+ Average analyst target of $14.67 implies 932.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:02 UTC

Back to Screener Export Report